TRANSCHEM LTD.-$ (TRANSCHEM) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of TRANSCHEM LTD.-$ ₹52.60, price ₹415, upside -87.3%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range ₹17.25 – ₹416.50 · fair‑value band ₹45.54 – ₹58.36 · the ₹415.15 price screens above the ₹52.60 fair value. Dashed = 300-day average. As of Oct 4, 2026.
Follow TRANSCHEM LTD.-$ in your weekly email
Every Wednesday you see whether TRANSCHEM LTD.-$ is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Transchem Limited does not have significant operations. Previously, it was engaged in the growing and processing of mushrooms. The company was incorporated in 1976 and is based in Thane, India.
Stock analysis
TRANSCHEM LTD.-$ (TRANSCHEM) currently trades at ₹415.15, while our model-based Fair Value estimate is ₹52.60, 87.3% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹75.70 per share, and 0 of the 7 models we run sit above the ₹415.15 price.
Bear case: the Earnings-Based group reads lowest at ₹24.32, and 7 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹45.54 (bear) to ₹58.36 (bull), the price of ₹415.15 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Financial Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
TRANSCHEM LTD.-$ reported revenue of ₹0 in FY2025 versus ₹0 in FY2021. Reported net income was ₹43.0M in FY2025, compounding +10.6%/yr from FY2021.
Key figures
Market cap ₹5.1B (≈ $52.8M) · P/E ratio 126.6 · EPS (TTM) ₹3.28 · Net margin 193% · Return on equity 5.3% · Return on assets (EBIT) −3.0% · Operating margin −14.7% · Revenue (TTM) ₹34.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 601% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −18% fair-value upside, at −87%, TRANSCHEM screens richer than that median.
Fair Value models
Bear ₹45.54Fair Value ₹52.60Bull ₹58.36
Price ₹415.15 · Upside -87.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (₹2.49 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.45/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 65 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside−87.3% · Bottom 25%
Profitability
Return on equity (TTM)5.3% · Top 25%
Return on assets−2.7% · Below median
Net margin (TTM)193.3% · Top 25%
Operating margin (TTM)−14.7% · Bottom 25%
Growth and dividend
Revenue growth991.2% · Top 25%
Valuation Multiplesvs Shell Companies median · lower = cheaper
P/E (TTM)126.6× · Priciest 25%
P/B6.08× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)100· sector 0
PAST (return on equity)21· sector 0
HEALTH (low debt)0· sector 100
DIVIDEND (yield)0· sector 0
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "TRANSCHEM LTD.-$ Fair Value". https://www.fairvalue-calculator.com/stock/TRANSCHEM
Frequently asked questions
Is TRANSCHEM LTD.-$ (TRANSCHEM) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of ₹52.60 versus a price of ₹415.15, about −87% upside (overvalued).
What is the fair value of TRANSCHEM?
Our model-based fair value for TRANSCHEM LTD.-$ is ₹52.60 (as of Oct 4, 2026), built from audited fundamentals. The current price: ₹415.15.
What is the quality score of TRANSCHEM?
TRANSCHEM LTD.-$ has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for TRANSCHEM LTD.-$ (TRANSCHEM)?
Our model-based price target is the fair value of ₹52.60 (as of Oct 4, 2026) from 7 valuation models. Cautious scenario ₹45.54, optimistic scenario ₹58.36. It is a calculation from audited fundamentals, not an analyst target.
What is the TRANSCHEM LTD.-$ stock forecast for 2026?
Our models put fair value at ₹52.60, about −87% upside versus a price of ₹415.15 (overvalued). Cautious scenario ₹45.54, optimistic scenario ₹58.36. The calculation is refreshed regularly with new filings.
What is the revenue of TRANSCHEM LTD.-$ (TRANSCHEM)?
TRANSCHEM LTD.-$ reported trailing-twelve-month revenue of about ₹34.8M (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of TRANSCHEM LTD.-$ (TRANSCHEM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For TRANSCHEM LTD.-$ it is ₹52.60 per share (as of Oct 4, 2026), against a price of ₹415.15. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is TRANSCHEM LTD.-$ stock overvalued or undervalued in 2026?
As of Oct 4, 2026, TRANSCHEM trades above its calculated fair value: price ₹415.15, fair value ₹52.60, a gap of about −87% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TRANSCHEM?
No. The price is what the market pays today (₹415.15); the fair value is what the company's own numbers justify (₹52.60). For TRANSCHEM LTD.-$ the two are ₹362.55 per share apart. That gap is exactly why we show both numbers side by side.
How much is TRANSCHEM LTD.-$ worth?
The market values TRANSCHEM LTD.-$ at about ₹5.1B (market capitalisation, as of Oct 4, 2026). Per share that is ₹415.15; our models calculate a fair value of ₹52.60 per share.
What do the bullish and bearish scenarios say about TRANSCHEM?
Our models span a range for TRANSCHEM LTD.-$: cautious scenario ₹45.54, base ₹52.60, optimistic ₹58.36 per share (as of Oct 4, 2026, price ₹415.15). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of TRANSCHEM?
TRANSCHEM LTD.-$ trades at a price-to-earnings ratio of 126.6 (as of Oct 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹52.60 is built from several models across several years. Other multiples: P/B 6.1.
How solid is the balance sheet of TRANSCHEM LTD.-$ (TRANSCHEM)?
Balance-sheet figures for TRANSCHEM LTD.-$ (as of Oct 4, 2026): return on equity 5.3%. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is TRANSCHEM from its 52-week high?
TRANSCHEM LTD.-$ trades at ₹415.15, at its 52-week high of ₹416.50 and 601% above the low of ₹59.24 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹52.60 is for.
Which stocks are comparable to TRANSCHEM LTD.-$?
From the same area (Financial Services) we also value Lionheart III Corp, AA Mission Acquisition Corp, Berto Acquisition Corp, Metals Acquisition Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is TRANSCHEM LTD.-$ stock attractive at the current price?
The data as of Oct 4, 2026: price ₹415.15, calculated fair value ₹52.60 (−87%), Quality Score 57/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TRANSCHEM calculated?
We run TRANSCHEM LTD.-$ through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹52.60, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. TRANSCHEM LTD.-$ itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of TRANSCHEM LTD.-$ (TRANSCHEM)?
The closing price on Oct 1, 2026 was ₹415.15. Our model-based fair value is ₹52.60, about −87% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with TRANSCHEM LTD.-$ right now?
The price sits above even our optimistic bull case (₹58.36). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of TRANSCHEM LTD.-$
How large is the market capitalisation of TRANSCHEM LTD.-$ (TRANSCHEM)?
The market capitalisation of TRANSCHEM LTD.-$ is ₹5.1B (≈ $52.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of TRANSCHEM LTD.-$ (TRANSCHEM)?
Earnings per share at TRANSCHEM LTD.-$ are ₹3.28 (price ÷ EPS = P/E 126.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of TRANSCHEM LTD.-$ (TRANSCHEM)?
The net margin of TRANSCHEM LTD.-$ is 193% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of TRANSCHEM LTD.-$ (TRANSCHEM)?
The return on equity (ROE) of TRANSCHEM LTD.-$ is 5.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of TRANSCHEM LTD.-$ (TRANSCHEM)?
On an EBIT basis the return on assets of TRANSCHEM LTD.-$ is −3.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of TRANSCHEM LTD.-$ (TRANSCHEM)?
The operating margin of TRANSCHEM LTD.-$ is −14.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at TRANSCHEM LTD.-$ (TRANSCHEM)?
Revenue at TRANSCHEM LTD.-$ is growing +991% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at TRANSCHEM LTD.-$ (TRANSCHEM)?
Earnings per share at TRANSCHEM LTD.-$ are growing −29.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does TRANSCHEM LTD.-$ (TRANSCHEM) generate?
The free cash flow of TRANSCHEM LTD.-$ is −₹15.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch TRANSCHEM LTD.-$ in the live analysis
One click puts TRANSCHEM LTD.-$ on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
